Copertina

Vadadustat in Patients with Anemia and Non–Dialysis-Dependent CKD

Salvato in:
Pubblicato in:The New England Journal of Medicine vol. 384, no. 17 (Apr 29, 2021), p. 1589
Autore principale: Pergola, Pablo E
Altri autori: Farag Youssef MK, Agarwal Rajiv, Arnold, Susan, Bako Gabriel, Block, Geoffrey A, Burke, Steven, Castillo, Fausto P, Jardine, Alan G, Khawaja Zeeshan, Koury, Mark J, Lewis, Eldrin F, Lin, Tim, Luo Wenli, Maroni, Bradley J, Matsushita Kunihiro, McCullough, Peter A, Parfrey, Patrick S, Roy-Chaudhury, Prabir, Sarnak, Mark J, Sharma, Amit, Spinowitz Bruce, Tseng, Carol, Tumlin, James, Vargo, Dennis L, Walters, Kimberly A, Winkelmayer, Wolfgang C, Wittes Janet, Eckardt Kai-Uwe
Pubblicazione:
Massachusetts Medical Society
Soggetti:
Akebia Therapeutics Inc
United States > US
Hemodialysis
Clinical trials
Hypoxia-inducible factors
Hemoglobin
Cerebral infarction
Collaboration
Kidney diseases
Heart failure
Hypoxia
Myocardial infarction
Confidence intervals
Erythropoietin
Thromboembolism
Drug dosages
Erythropoiesis
Patients
Hydroxylase
Anemia
Heart attacks
Prolyl hydroxylase
Design
Safety
Congestive heart failure
Dialysis
Accesso online:Citation/Abstract
Full Text
Full Text - PDF
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
Lascia un commento!
Entra